World Congress on PD & Related Disorders

Parkinson's Disease Congress

In 2009 the XVIII WFN World Congress on Parkinson's Disease and Related Disorders celebrates half a century as a leading international summit for clinicians, researchers, and allied healthcare professionals worldwide seeking real solutions to improve the long-term outcomes for Parkinson's patients.

Over 3,000 participants are expected to attend this biennial Parkinson's Disease congress - the eighteenth organized by the World Federation of Neurology (WFN) 'Research Group on Parkinsonism and Related Disorders'.

Find more information on this conference here.

Responses:
New support for an old hypothesis: Toxic dopamine metabolites are key players in neuronal loss in PD when the intrinsic protection mechanisms fail.
Franziska Richter, UCLA
14 Dec 2009 11:04 PM EST
P1.217 Decreased putamen aldehyde dehydrogenase in Parkinson disease D. Goldstein, P. Sullivan, C. Holmes, I. Kopin, M. Basile ... 
Miami Nice (I) - New Gene for PD?
Mark Cookson, NIH
15 Dec 2009 07:10 PM EST
Many exciting things at the WFN Congress in Miami today, but for me the highlight was a newly nominated gene for PD, EIF4G1, presented in both poster and platform forums by Matt Farrer, Mayo Clinic ... 
Responses: 1
Quality of life in PD patients: Depression as a key determinant
Franziska Richter, UCLA
16 Dec 2009 01:15 PM EST
In several discussions at this WFN conference it was emphasized that non-motor symptoms are critical for the quality of life in patients. In the poster cited below, Lena and Meike found that the ... 
A Randomized, Double-Blind, Placebo Controlled, Delayed Start Study to Assess Safety, Tolerability and Efficacy of Green Tea Polyphenols in Parkinson's Disease
Piu Chan, CCMU
16 Dec 2009 05:43 PM EST
Both case-control and incident epidemiological studies in different ethnic populations have shown that tea drinking is associated with a dose-dependent reduction of risk for Parkinson´s ... 
Quality of life in PD patients: an empirical study on beneficial effects of gum chewing
Franziska Richter, UCLA
16 Dec 2009 05:48 PM EST
At WFN, in the poster cited below, neurologist Dr. Mandar Jog and speech language pathologists Angie South and Stephanie Somers of the London Health Sciences Centre (LHSC) investigate possible ... 
Chair session summary from WFN 2009: What is the Future of the alpha-synuclein story and PD?
Leonidas Stefanis, Academy of Athens
18 Dec 2009 10:08 AM EST
Dr. Stefanis argued that it is the synergy of multiple pieces of evidence from Mendelian genetics, population genetics, human pathology, animal models and biochemistry that suggests that ... 
Re: Miami Nice (I) - New Gene for PD?
Brian K. Fiske, MJFF
18 Dec 2009 09:07 PM EST
Very interesting...Was this in a region that was linked to a known PARK loci or is this a novel locus? ... 
How do we define PD?
Anthony E Lang, UofT
23 Dec 2009 02:01 PM EST
Dr. Anthony Lang has posted his slides from his introductory presentation on "How Do We Define PD?" at the 2009 WFN World Congress:  ... 
THALAMIC CHANGES IN PARKINSON'S DISEASE
Jose L Lanciego, CIMA
24 Dec 2009 04:35 AM EST
At present, the thalamus has been regarded as a relay station between the basal ganglia output and the cerebral cortex. However, more recently it has been realized that the thalamus also is ... 
Dystonia session highlights
Susan Bressman, Beth Israel
24 Dec 2009 11:12 AM EST
The dystonia session highlighted DBS as this has really revolutionized our treatment over the last 5-6 years. Marie Vidailhet and Tipu Aziz reviewed current findings - confirming and extending ... 
Are growth factors the answer?
Franz F Hefti, Avid
28 Dec 2009 06:15 PM EST
This forum-style symposium dealt with the question whether neurotrophic factors or growth factors remain a viable approach to PD therapy despite earlier setbacks.  ... 
New Targets for DBS
Alberto Albanese, Catholic University
4 Jan 2010 10:55 AM EST
Non motor effects of pedunculopontine nucleus stimulation ... 
Update on the pathophysiology and medical and surgical treatment of PD
Raul de la Fuente-Fernandez, PPRC
6 Jan 2010 05:22 PM EST
On December 14, 2009, at the XVIII WFN World Congress on Parkinson’s Disease and Related Disorders in Miami, Drs. Jose Obeso, Pedro Chana, and Andres Lozano provided an update on the ... 
Treatment of PD-related Dysautonomia
Joseph Jankovic, Baylor
7 Jan 2010 02:43 PM EST
Find Dr. Joseph Jankovic's slides from his session on "Treatment of PD-related Dysautonomia" at the WFN World Congress on Parkinson's Disease and Related Disorders. -PDOR Editor   ... 
Movement related frequency modulation of alpha oscillatory activity in human basal ganglia
Arun Singh, LMU
12 Jan 2010 08:53 AM EST
Aims: Depth recordings from the basal ganglia of Parkinson patients and dystonic patients have revealed exaggerated local field potential (LFP) activity at alpha (α), beta (β) and gamma ... 
Session Summary: Disease modification in early PD
C. Warren Olanow, Mt. Sinai
13 Jan 2010 01:27 PM EST
A drug that slows disease progression or is “neuroprotective” is the most urgent priority in the management of Parkinson’s disease. At the recent International Parkinson Disease ... 
News:
Attending the WFN World Congress on Parkinson's in Miami?
We need your help! We want to hear about the science presented in Miami - what are the hottest topics this year? ... 
01 Dec 2009